Skip to content

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

News

Select Year
Clinical Trials
Search …

March 19, 2007

Oncolytics Biotech Inc. Research Collaborators Present Combination Reovirus and Cyclophosphamide Treatment Results at International Oncolytic Virus Conference

March 16, 2007

Oncolytics Biotech Inc. Research Collaborators to Present Reovirus Treatment in Melanoma Animal Models at International Oncolytic Virus Conference

March 16, 2007

Oncolytics Biotech Inc. Research Collaborators to Present Combination Reovirus and Cisplatin Treatment Results at Oncolytic Virus Conference

March 15, 2007

Media advisory – Oncolytics Biotech Inc. to Present at Invest Northwest CEO and Investor Conference

March 13, 2007

Oncolytics Biotech Inc. Collaborators to Present Reovirus/Gemcitabine Combination Research at AACR Annual Meeting

March 6, 2007

Oncolytics Biotech Inc. Announces Issuance of 19th U.S. Patent

March 2, 2007

Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2006

February 22, 2007

Oncolytics Biotech Inc. Announces Closing of Public Share Offering

February 6, 2007

Oncolytics Biotech Inc. Announces Pricing of Previously Announced Public Offering

February 5, 2007

Oncolytics Biotech Inc. Announces Public Offering

Page 70 of 71

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Email: jpatton@oncolytics.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Loading...

4350 Executive Drive
Suite 325
San Diego, CA 92121
info@oncolyticsbiotech.com

Company

Our Mission
Leadership
Board of Directors
Careers
Contact

Science

Our Science
Pipeline
Resources

Investors

Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs

Privacy Policy Accessibility Cookie Policy Disclaimer Manage Consent

Copyright © 2026 Oncolytics Biotech Inc.